RTD Financial Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.66M Sell
58,168
-282
-0.5% -$7.5K 0.18% 65
2026
Q2
$1.41M Buy
58,450
+4,866
+9% +$127K 0.15% 67
2026
Q1
$1.5M Buy
53,584
+651
+1% +$17.3K 0.18% 62
2025
Q4
$1.32M Buy
52,933
+952
+2% +$24K 0.16% 60
2025
Q3
$1.32M Hold
51,981
– – 0.16% 59
2025
Q2
$1.26M Sell
51,981
-711
-1% -$16.6K 0.16% 59
2025
Q1
$1.34M Buy
52,692
+636
+1% +$16.6K 0.18% 57
2024
Q4
$1.38M Sell
52,056
-100
-0.2% -$2.71K 0.18% 57
2024
Q3
$1.51M Buy
52,156
+175
+0.3% +$5.11K 0.19% 56
2024
Q2
$1.45M Hold
51,981
– – 0.2% 57
2024
Q1
$1.44M Hold
51,981
– – 0.19% 55
2023
Q4
$1.5M Sell
51,981
-300
-0.6% -$9.07K 0.21% 53
2023
Q3
$1.73M Hold
52,281
– – 0.26% 52
2023
Q2
$1.92M Sell
52,281
-652
-1% -$25.4K 0.28% 49
2023
Q1
$2.16M Buy
52,933
+652
+1% +$28.2K 0.33% 46
2022
Q4
$2.68M Sell
52,281
-3,277
-6% -$157K 0.44% 41
2022
Q3
$2.43M Sell
55,558
-7,943
-13% -$386K 0.45% 43
2022
Q2
$3.33M Sell
63,501
-167
-0.3% -$8.51K 0.51% 45
2022
Q1
$3.3M Buy
63,668
+206
+0.3% +$10.7K 0.45% 42
2021
Q4
$3.75M Buy
+63,462
New +$3.14M 0.49% 42

Other funds holding PFE

RTD Financial Advisors's PFE Position: Q3 2026 in Review

RTD Financial Advisors reduced its Pfizer (PFE) stake by 0.48% in Q3 2026, selling an estimated $7.5K and leaving 58,168 shares worth $1.66M. The position accounts for 0.18% of the portfolio, ranked #65.

RTD Financial Advisors first reported a position in PFE in Q4 2021 and has held it in 20 quarters since. The position peaked at $3.75M in Q4 2021. 156 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • RTD Financial Advisors held 58,168 shares of Pfizer worth $1.66M as of Q3 2026.
  • RTD Financial Advisors sold 282 Pfizer shares in Q3 2026, an estimated $7.5K.
  • Pfizer made up 0.18% of RTD Financial Advisors's portfolio in Q3 2026, its #65 holding.
  • RTD Financial Advisors first reported a position in Pfizer in Q4 2021 and has held it in 20 quarters since.
  • RTD Financial Advisors's Pfizer position peaked at $3.75M in Q4 2021.
  • 156 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on RTD Financial Advisors's 13F filing for Q3 2026, filed 9 Oct 2026.